Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial
Title:
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial
Author:
Ochoge, Magnus Futa, Ahmed Cherno Umesi, Ama Affleck, Lucy Kotei, Larry Daffeh, Baboucarr Saidy-Jah, Ebrima Njie, Anna Oyadiran, Oluwafemi Edem, Bassey Jallow, Musa Jallow, Edrissa Donkor, Simon A Tritama, Erman Abid, Talha Jones, Kathryn A V Mainou, Bernardo A Konz, John O Fix, Alan Gast, Chris Clarke, Ed
Appeared in:
Lancet
Paging:
Volume 403 () nr. 10432 pages 1164-1175
Year:
2024
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license